| Year |
Citation |
Score |
| 2019 |
Lamine A, de Molliens MP, Létourneau M, Hébert TE, Vaudry D, Fournier A, Chatenet D. The amidated PACAP fragment is a potent reduced-size neuroprotective agent. Biochimica Et Biophysica Acta. General Subjects. PMID 31401178 DOI: 10.1016/J.Bbagen.2019.08.003 |
0.36 |
|
| 2019 |
de Molliens MP, Jamadagni P, Létourneau M, Devost D, Hébert TE, Patten SA, Fournier A, Chatenet D. Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor. Biochimica Et Biophysica Acta. General Subjects. PMID 31306709 DOI: 10.1016/J.Bbagen.2019.07.007 |
0.435 |
|
| 2019 |
Merabet N, Nsaibia MJ, Nguyen QT, Shi YF, Letourneau M, Fournier A, Tardif JC, Harel F, Dupuis J. PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension. Scientific Reports. 9: 6609. PMID 31036871 DOI: 10.1038/S41598-019-43225-3 |
0.319 |
|
| 2018 |
de Molliens MP, Létourneau M, Devost D, Hébert TE, Fournier A, Chatenet D. New insights about the peculiar role of the 28-38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection. Biochemical Pharmacology. PMID 29704474 DOI: 10.1016/J.Bcp.2018.04.024 |
0.377 |
|
| 2018 |
Cabezas-Llobet N, Vidal-Sancho L, Masana M, Fournier A, Alberch J, Vaudry D, Xifró X. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease. Molecular Neurobiology. 55: 8263-8277. PMID 29526016 DOI: 10.1007/S12035-018-0972-5 |
0.313 |
|
| 2016 |
Therrien A, Fournier A, Lafleur M. Role of the Cationic C-Terminal Segment of Melittin on Membrane Fragmentation. The Journal of Physical Chemistry. B. PMID 27054924 DOI: 10.1021/Acs.Jpcb.5B11705 |
0.313 |
|
| 2016 |
Douiri S, Bahdoudi S, Hamdi Y, Cubì R, Basille M, Fournier A, Vaudry H, Tonon MC, Amri M, Vaudry D, Masmoudi-Kouki O. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes. Journal of Neurochemistry. PMID 26991551 DOI: 10.1111/Jnc.13614 |
0.318 |
|
| 2016 |
Boisvilliers Md, Perrin F, Hebache S, Balandre AC, Bensalma S, Garnier A, Vaudry D, Fournier A, Festy F, Muller JM, Chadéneau C. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells. Peptides. 78: 30-41. PMID 26826611 DOI: 10.1016/J.Peptides.2016.01.014 |
0.372 |
|
| 2016 |
Lamine-Ajili A, Fahmy AM, Létourneau M, Chatenet D, Labonté P, Vaudry D, Fournier A. Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease. Biochimica Et Biophysica Acta. 1862: 688-95. PMID 26769362 DOI: 10.1016/J.Bbadis.2016.01.005 |
0.329 |
|
| 2015 |
Doan ND, Poujol de Molliens M, Létourneau M, Fournier A, Chatenet D. Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure-activity relationship study of a class B GPCR ligand. European Journal of Medicinal Chemistry. 104: 106-14. PMID 26448038 DOI: 10.1016/J.Ejmech.2015.09.017 |
0.744 |
|
| 2015 |
Tadevosyan A, Villeneuve LR, Fournier A, Chatenet D, Nattel S, Allen BG. Caged ligands to study the role of intracellular GPCRs. Methods (San Diego, Calif.). PMID 26196333 DOI: 10.1016/J.Ymeth.2015.07.005 |
0.351 |
|
| 2015 |
Lamine A, Létourneau M, Doan ND, Maucotel J, Couvineau A, Vaudry H, Chatenet D, Vaudry D, Fournier A. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model. Neuropharmacology. PMID 26006268 DOI: 10.1016/J.Neuropharm.2015.05.014 |
0.72 |
|
| 2015 |
Vaudry H, Leprince J, Chatenet D, Fournier A, Lambert DG, Le Mével JC, Ohlstein EH, Schwertani A, Tostivint H, Vaudry D. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function. Pharmacological Reviews. 67: 214-58. PMID 25535277 DOI: 10.1124/Pr.114.009480 |
0.429 |
|
| 2015 |
Tadevosyan A, Létourneau M, Folch B, Doucet N, Villeneuve LR, Mamarbachi AM, Pétrin D, Hébert TE, Fournier A, Chatenet D, Allen BG, Nattel S. Photoreleasable ligands to study intracrine angiotensin II signalling. The Journal of Physiology. 593: 521-39. PMID 25433071 DOI: 10.1113/Jphysiol.2014.279109 |
0.335 |
|
| 2015 |
Chatenet D, Bourgault S, Fournier A. Design and application of light-activated probes for cellular signaling. Methods in Molecular Biology (Clifton, N.J.). 1234: 17-30. PMID 25304345 DOI: 10.1007/978-1-4939-1755-6_3 |
0.405 |
|
| 2014 |
Tchoumi Neree A, Nguyen PT, Chatenet D, Fournier A, Bourgault S. Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP. Febs Letters. 588: 4590-6. PMID 25447531 DOI: 10.1016/J.Febslet.2014.10.029 |
0.384 |
|
| 2014 |
Seaborn T, Ravni A, Au R, Chow BK, Fournier A, Wurtz O, Vaudry H, Eiden LE, Vaudry D. Induction of serpinb1a by PACAP or NGF is required for PC12 cells survival after serum withdrawal. Journal of Neurochemistry. 131: 21-32. PMID 24899316 DOI: 10.1111/Jnc.12780 |
0.325 |
|
| 2014 |
Raoult E, Bénard M, Komuro H, Lebon A, Vivien D, Fournier A, Vaudry H, Vaudry D, Galas L. Cortical-layer-specific effects of PACAP and tPA on interneuron migration during post-natal development of the cerebellum. Journal of Neurochemistry. 130: 241-54. PMID 24646324 DOI: 10.1111/Jnc.12714 |
0.31 |
|
| 2013 |
Chatenet D, Folch B, Feytens D, Létourneau M, Tourwé D, Doucet N, Fournier A. Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists. Journal of Medicinal Chemistry. 56: 9612-22. PMID 24251366 DOI: 10.1021/Jm401153J |
0.447 |
|
| 2013 |
Merlen C, Farhat N, Luo X, Chatenet D, Tadevosyan A, Villeneuve LR, Gillis MA, Nattel S, Thorin E, Fournier A, Allen BG. Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⺠in adult cardiac myocytes. Journal of Molecular and Cellular Cardiology. 62: 189-202. PMID 23756157 DOI: 10.1016/J.Yjmcc.2013.05.021 |
0.362 |
|
| 2013 |
Vaniotis G, Glazkova I, Merlen C, Smith C, Villeneuve LR, Chatenet D, Therien M, Fournier A, Tadevosyan A, Trieu P, Nattel S, Hébert TE, Allen BG. Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors. Journal of Molecular and Cellular Cardiology. 62: 58-68. PMID 23684854 DOI: 10.1016/J.Yjmcc.2013.05.003 |
0.391 |
|
| 2013 |
Basille-Dugay M, Vaudry H, Fournier A, Gonzalez B, Vaudry D. Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels. Frontiers in Endocrinology. 4: 56. PMID 23675369 DOI: 10.3389/Fendo.2013.00056 |
0.324 |
|
| 2013 |
Chatenet D, Létourneau M, Nguyen QT, Doan ND, Dupuis J, Fournier A. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation. British Journal of Pharmacology. 168: 807-21. PMID 22994258 DOI: 10.1111/J.1476-5381.2012.02217.X |
0.754 |
|
| 2012 |
Chatenet D, Nguyen TT, Létourneau M, Fournier A. Update on the urotensinergic system: new trends in receptor localization, activation, and drug design. Frontiers in Endocrinology. 3: 174. PMID 23293631 DOI: 10.3389/Fendo.2012.00174 |
0.393 |
|
| 2012 |
Doan ND, Létourneau M, Vaudry D, Doucet N, Folch B, Vaudry H, Fournier A, Chatenet D. Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 256-65. PMID 22922050 DOI: 10.1016/J.Jconrel.2012.08.021 |
0.743 |
|
| 2012 |
Doan ND, Chatenet D, Létourneau M, Vaudry H, Vaudry D, Fournier A. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochimica Et Biophysica Acta. 1823: 940-9. PMID 22343001 DOI: 10.1016/J.Bbamcr.2012.02.001 |
0.769 |
|
| 2012 |
Nguyen TT, Létourneau M, Chatenet D, Fournier A. Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulation. The International Journal of Biochemistry & Cell Biology. 44: 639-47. PMID 22245063 DOI: 10.1016/J.Biocel.2011.12.022 |
0.435 |
|
| 2012 |
Chatenet D, Nguyen QT, Létourneau M, Dupuis J, Fournier A. Urocontrin, a novel UT receptor ligand with a unique pharmacological profile. Biochemical Pharmacology. 83: 608-15. PMID 22197588 DOI: 10.1016/J.Bcp.2011.12.009 |
0.417 |
|
| 2012 |
Doan ND, Nguyen TT, Létourneau M, Turcotte K, Fournier A, Chatenet D. Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart. British Journal of Pharmacology. 166: 243-57. PMID 22044114 DOI: 10.1111/J.1476-5381.2011.01710.X |
0.729 |
|
| 2012 |
Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology. 62: 200-8. PMID 21803058 DOI: 10.1016/J.Neuropharm.2011.06.030 |
0.346 |
|
| 2011 |
El Kebir D, Zhang Y, Potempa LA, Wu Y, Fournier A, Filep JG. C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32. Journal of Leukocyte Biology. 90: 1167-75. PMID 21934067 DOI: 10.1189/Jlb.0111032 |
0.358 |
|
| 2011 |
Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP. Journal of Neurochemistry. 119: 920-31. PMID 21919910 DOI: 10.1111/J.1471-4159.2011.07486.X |
0.365 |
|
| 2011 |
Tam JK, Lau KW, Lee LT, Chu JY, Ng KM, Fournier A, Vaudry H, Chow BK. Origin of secretin receptor precedes the advent of tetrapoda: evidence on the separated origins of secretin and orexin. Plos One. 6: e19384. PMID 21559418 DOI: 10.1371/Journal.Pone.0019384 |
0.405 |
|
| 2011 |
Bourgault S, Chatenet D, Wurtz O, Doan ND, Leprince J, Vaudry H, Fournier A, Vaudry D. Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Current Pharmaceutical Design. 17: 1002-24. PMID 21524253 DOI: 10.2174/138161211795589337 |
0.737 |
|
| 2011 |
Dejda A, Seaborn T, Bourgault S, Touzani O, Fournier A, Vaudry H, Vaudry D. PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action. Peptides. 32: 1207-16. PMID 21514338 DOI: 10.1016/J.Peptides.2011.04.003 |
0.38 |
|
| 2011 |
Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D. Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Current Pharmaceutical Design. 17: 204-14. PMID 21348830 DOI: 10.2174/138161211795049679 |
0.356 |
|
| 2011 |
Masmoudi-Kouki O, Douiri S, Hamdi Y, Kaddour H, Bahdoudi S, Vaudry D, Basille M, Leprince J, Fournier A, Vaudry H, Tonon MC, Amri M. Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis. Journal of Neurochemistry. 117: 403-11. PMID 21244427 DOI: 10.1111/J.1471-4159.2011.07185.X |
0.352 |
|
| 2011 |
Dejda A, Bourgault S, Doan ND, Létourneau M, Couvineau A, Vaudry H, Vaudry D, Fournier A. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP. Biochimie. 93: 669-77. PMID 21185349 DOI: 10.1016/J.Biochi.2010.12.010 |
0.748 |
|
| 2011 |
Doan ND, Bourgault S, Dejda A, Létourneau M, Detheux M, Vaudry D, Vaudry H, Chatenet D, Fournier A. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochemical Pharmacology. 81: 552-61. PMID 21114961 DOI: 10.1016/J.Bcp.2010.11.015 |
0.754 |
|
| 2011 |
Botia B, Jolivel V, Burel D, Le Joncour V, Roy V, Naassila M, Bénard M, Fournier A, Vaudry H, Vaudry D. Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum. Neurotoxicity Research. 19: 423-34. PMID 20422475 DOI: 10.1007/S12640-010-9186-Y |
0.315 |
|
| 2010 |
Vaudry H, Do Rego JC, Le Mevel JC, Chatenet D, Tostivint H, Fournier A, Tonon MC, Pelletier G, Conlon JM, Leprince J. Urotensin II, from fish to human. Annals of the New York Academy of Sciences. 1200: 53-66. PMID 20633133 DOI: 10.1111/J.1749-6632.2010.05514.X |
0.386 |
|
| 2010 |
Dejda A, Chan P, Seaborn T, Coquet L, Jouenne T, Fournier A, Vaudry H, Vaudry D. Involvement of stathmin 1 in the neurotrophic effects of PACAP in PC12 cells. Journal of Neurochemistry. 114: 1498-510. PMID 20569302 DOI: 10.1111/J.1471-4159.2010.06873.X |
0.366 |
|
| 2010 |
Allais A, Burel D, Roy V, Arthaud S, Galas L, Isaac ER, Desfeux A, Parent B, Fournier A, Chapillon P, Sherwood NM, Vaudry H, Gonzalez BJ. Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization. Journal of Neurochemistry. 113: 329-40. PMID 20050979 DOI: 10.1111/J.1471-4159.2009.06555.X |
0.325 |
|
| 2010 |
Mahaut S, Dumont Y, Fournier A, Quirion R, Moyse E. Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat. Neuropeptides. 44: 77-86. PMID 19880180 DOI: 10.1016/J.Npep.2009.10.001 |
0.39 |
|
| 2009 |
Bourgault S, Vaudry D, Dejda A, Doan ND, Vaudry H, Fournier A. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Current Medicinal Chemistry. 16: 4462-80. PMID 19835562 DOI: 10.2174/092986709789712899 |
0.767 |
|
| 2009 |
Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacological Reviews. 61: 283-357. PMID 19805477 DOI: 10.1124/Pr.109.001370 |
0.475 |
|
| 2009 |
Hong Y, Liu Y, Chabot JG, Fournier A, Quirion R. Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats. Pain. 146: 105-13. PMID 19683388 DOI: 10.1016/J.Pain.2009.07.015 |
0.342 |
|
| 2009 |
Fu Y, Létourneau M, Nguyen QT, Chatenet D, Dupuis J, Fournier A. Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging. European Journal of Pharmacology. 617: 118-23. PMID 19559019 DOI: 10.1016/J.Ejphar.2009.06.031 |
0.402 |
|
| 2009 |
Dupuis J, Harel F, Fu Y, Nguyen QT, Letourneau M, Préfontaine A, Fournier A. Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1110-5. PMID 19525474 DOI: 10.2967/Jnumed.108.059428 |
0.306 |
|
| 2009 |
Bourgault S, Vaudry D, Ségalas-Milazzo I, Guilhaudis L, Couvineau A, Laburthe M, Vaudry H, Fournier A. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. Journal of Medicinal Chemistry. 52: 3308-16. PMID 19413310 DOI: 10.1021/Jm900291J |
0.42 |
|
| 2009 |
Jolivel V, Basille M, Aubert N, de Jouffrey S, Ancian P, Le Bigot JF, Noack P, Massonneau M, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience. 160: 434-51. PMID 19236905 DOI: 10.1016/J.Neuroscience.2009.02.028 |
0.378 |
|
| 2009 |
Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 424-35. PMID 18536705 DOI: 10.1038/Npp.2008.73 |
0.336 |
|
| 2008 |
Aubert N, Vaudry D, Falluel-Morel A, Desfeux A, Fisch C, Ancian P, de Jouffrey S, Le Bigot JF, Couvineau A, Laburthe M, Fournier A, Laudenbach V, Vaudry H, Gonzalez BJ. PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway. Neurobiology of Disease. 32: 66-80. PMID 18652895 DOI: 10.1016/J.Nbd.2008.06.014 |
0.335 |
|
| 2008 |
Dejda A, Jolivel V, Bourgault S, Seaborn T, Fournier A, Vaudry H, Vaudry D. Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. Journal of Molecular Neuroscience : Mn. 36: 26-37. PMID 18506634 DOI: 10.1007/S12031-008-9087-1 |
0.376 |
|
| 2008 |
Botia B, Seyer D, Ravni A, Bénard M, Falluel-Morel A, Cosette P, Jouenne T, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D. Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons. Journal of Molecular Neuroscience : Mn. 36: 61-72. PMID 18491044 DOI: 10.1007/S12031-008-9075-5 |
0.351 |
|
| 2008 |
Bourgault S, Vaudry D, Guilhaudis L, Raoult E, Couvineau A, Laburthe M, Ségalas-Milazzo I, Vaudry H, Fournier A. Biological and structural analysis of truncated analogs of PACAP27. Journal of Molecular Neuroscience : Mn. 36: 260-9. PMID 18473187 DOI: 10.1007/S12031-008-9081-7 |
0.39 |
|
| 2008 |
Boivin S, Ségalas-Milazzo I, Guilhaudis L, Oulyadi H, Fournier A, Davoust D. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II. Peptides. 29: 700-10. PMID 18423797 DOI: 10.1016/J.Peptides.2008.02.024 |
0.309 |
|
| 2008 |
Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H, Fournier A. Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides. 29: 919-32. PMID 18353507 DOI: 10.1016/J.Peptides.2008.01.022 |
0.43 |
|
| 2008 |
Aubin J, Létourneau M, Francoeur E, Burgeon E, Fournier A. Identification of ETA and ETB binding domains using ET-derived photoprobes. Biochimie. 90: 918-29. PMID 18343229 DOI: 10.1016/J.Biochi.2008.02.015 |
0.409 |
|
| 2008 |
Grumolato L, Ghzili H, Montero-Hadjadje M, Gasman S, Lesage J, Tanguy Y, Galas L, Ait-Ali D, Leprince J, Guérineau NC, Elkahloun AG, Fournier A, Vieau D, Vaudry H, Anouar Y. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1756-68. PMID 18198219 DOI: 10.1096/Fj.06-075820 |
0.317 |
|
| 2008 |
Doan ND, Bourgault S, Létourneau M, Fournier A. Effectiveness of the suzuki-miyaura cross-coupling reaction for solid-phase peptide modification. Journal of Combinatorial Chemistry. 10: 44-51. PMID 18067269 DOI: 10.1021/Cc700128B |
0.713 |
|
| 2008 |
Parat M, McNicoll N, Wilkes B, Fournier A, De Léan A. Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A. Molecular Pharmacology. 73: 431-40. PMID 17965196 DOI: 10.1124/Mol.107.039982 |
0.428 |
|
| 2008 |
Leprince J, Chatenet D, Dubessy C, Fournier A, Pfeiffer B, Scalbert E, Renard P, Pacaud P, Oulyadi H, Ségalas-Milazzo I, Guilhaudis L, Davoust D, Tonon MC, Vaudry H. Structure-activity relationships of urotensin II and URP. Peptides. 29: 658-73. PMID 17931747 DOI: 10.1016/J.Peptides.2007.08.014 |
0.373 |
|
| 2007 |
Dumont Y, Moyse E, Fournier A, Quirion R. Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. Journal of Molecular Neuroscience : Mn. 33: 294-304. PMID 17952639 DOI: 10.1007/S12031-007-9007-9 |
0.365 |
|
| 2007 |
Aubert N, Basille M, Falluel-Morel A, Vaudry D, Bucharles C, Jolivel V, Fisch C, De Jouffrey S, Le Bigot JF, Fournier A, Vaudry H, Gonzalez BJ. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys. The Journal of Comparative Neurology. 504: 427-39. PMID 17663433 DOI: 10.1002/Cne.21451 |
0.377 |
|
| 2007 |
Masmoudi-Kouki O, Gandolfo P, Castel H, Leprince J, Fournier A, Dejda A, Vaudry H, Tonon MC. Role of PACAP and VIP in astroglial functions. Peptides. 28: 1753-60. PMID 17655978 DOI: 10.1016/J.Peptides.2007.05.015 |
0.333 |
|
| 2007 |
Botia B, Basille M, Allais A, Raoult E, Falluel-Morel A, Galas L, Jolivel V, Wurtz O, Komuro H, Fournier A, Vaudry H, Burel D, Gonzalez BJ, Vaudry D. Neurotrophic effects of PACAP in the cerebellar cortex. Peptides. 28: 1746-52. PMID 17544170 DOI: 10.1016/J.Peptides.2007.04.013 |
0.367 |
|
| 2007 |
Viau M, Létourneau M, Sirois-Deslongchamps A, Boulanger Y, Fournier A. Study of solid-phase synthesis and purification strategies for the preparation of polyglutamine peptides. Biopolymers. 88: 754-63. PMID 17516502 DOI: 10.1002/Bip.20763 |
0.356 |
|
| 2007 |
Falluel-Morel A, Chafai M, Vaudry D, Basille M, Cazillis M, Aubert N, Louiset E, de Jouffrey S, Le Bigot JF, Fournier A, Gressens P, Rostène W, Vaudry H, Gonzalez BJ. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. Journal of Neuroendocrinology. 19: 321-7. PMID 17425606 DOI: 10.1111/J.1365-2826.2007.01537.X |
0.413 |
|
| 2007 |
Bourgault S, Létourneau M, Fournier A. Development of photolabile caged analogs of endothelin-1. Peptides. 28: 1074-82. PMID 17400333 DOI: 10.1016/J.Peptides.2007.02.013 |
0.351 |
|
| 2006 |
Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. Journal of Neurochemistry. 99: 1237-50. PMID 17026529 DOI: 10.1111/J.1471-4159.2006.04148.X |
0.308 |
|
| 2006 |
Basille M, Falluel-Morel A, Vaudry D, Aubert N, Fournier A, Fréger P, Gallo-Payet N, Vaudry H, Gonzalez B. Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications. Regulatory Peptides. 137: 27-33. PMID 16963135 DOI: 10.1016/J.Regpep.2006.03.010 |
0.357 |
|
| 2006 |
Guillemot J, Aït-Ali D, Turquier V, Montero-Hadjadje M, Fournier A, Vaudry H, Anouar Y, Yon L. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells. Regulatory Peptides. 137: 79-88. PMID 16963134 DOI: 10.1016/J.Regpep.2006.04.023 |
0.379 |
|
| 2006 |
Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jégou S. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience. 143: 155-163. PMID 16962718 DOI: 10.1016/J.Neuroscience.2006.07.022 |
0.379 |
|
| 2006 |
Okada R, Yamamoto K, Ito Y, Chartrel N, Leprince J, Fournier A, Vaudry H, Kikuyama S. Effects of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide, and somatostatin on the release of thyrotropin from the bullfrog pituitary. Annals of the New York Academy of Sciences. 1070: 474-80. PMID 16888212 DOI: 10.1196/Annals.1317.064 |
0.301 |
|
| 2006 |
Montero-Hadjadje M, Delarue C, Fournier A, Vaudry H, Yon L. Involvement of the adenylyl cyclase/protein kinase A signaling pathway in the stimulatory effect of PACAP on frog adrenocortical cells. Annals of the New York Academy of Sciences. 1070: 431-5. PMID 16888205 DOI: 10.1196/Annals.1317.057 |
0.306 |
|
| 2006 |
Masmoudi-Kouki O, Gandolfo P, Leprince J, Vaudry D, Pelletier G, Fournier A, Vaudry H, Tonon MC. PACAP stimulates biosynthesis and release of endozepines from rat astrocytes. Annals of the New York Academy of Sciences. 1070: 411-6. PMID 16888201 DOI: 10.1196/Annals.1317.094 |
0.374 |
|
| 2006 |
Lebon A, Seyer D, Cosette P, Coquet L, Jouenne T, Chan P, Leprince J, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D. Identification of proteins regulated by PACAP in PC12 cells by 2D gel electrophoresis coupled to mass spectrometry. Annals of the New York Academy of Sciences. 1070: 380-7. PMID 16888196 DOI: 10.1196/Annals.1317.049 |
0.305 |
|
| 2006 |
Guillemot J, Ait-Ali D, Turquier V, Montero-Hadjadje M, Fournier A, Vaudry H, Anouar Y, Yon L. PACAP stimulates the release of the secretogranin II-derived peptide EM66 from chromaffin cells. Annals of the New York Academy of Sciences. 1070: 309-12. PMID 16888183 DOI: 10.1196/Annals.1317.033 |
0.356 |
|
| 2006 |
Falluel-Morel A, Vaudry D, Aubert N, Galas L, Benard M, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. PACAP and ceramides exert opposite effects on migration, neurite outgrowth, and cytoskeleton remodeling. Annals of the New York Academy of Sciences. 1070: 265-70. PMID 16888176 DOI: 10.1196/Annals.1317.024 |
0.327 |
|
| 2006 |
Ravni A, Bourgault S, Lebon A, Chan P, Galas L, Fournier A, Vaudry H, Gonzalez B, Eiden LE, Vaudry D. The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. Journal of Neurochemistry. 98: 321-9. PMID 16805827 DOI: 10.1111/J.1471-4159.2006.03884.X |
0.364 |
|
| 2006 |
Vallarino M, Bruzzone F, Mathieu M, Chartrel N, Vieau D, Ciarlo M, Fournier A, Vaudry H. Ontogeny of the somatostatin variant [Pro2,Met13]somatostatin-14 in the brain, pituitary, and sensory organs of the frog Rana esculenta. The Journal of Comparative Neurology. 497: 717-33. PMID 16786560 DOI: 10.1002/Cne.20986 |
0.313 |
|
| 2006 |
Takhshid MA, Poyner DR, Chabot JG, Fournier A, Ma W, Zheng WH, Owji AA, Quirion R. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. British Journal of Pharmacology. 148: 459-68. PMID 16702994 DOI: 10.1038/Sj.Bjp.0706750 |
0.44 |
|
| 2006 |
Boivin S, Guilhaudis L, Milazzo I, Oulyadi H, Davoust D, Fournier A. Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide. Biochemistry. 45: 5993-6002. PMID 16681371 DOI: 10.1021/Bi060190B |
0.361 |
|
| 2006 |
Yon L, Chartrel N, Montero M, Bellancourt G, Feuilloley M, Pelletier G, Roubos E, Arimura A, Conlon JM, Fournier A, Vaudry H. Pituitary Adenylate Cyclase‐Activating Polypeptide Regulates Both Adrenocortical and Chromaffin Cell Activity in the Frog Adrenal Glanda Annals of the New York Academy of Sciences. 805: 697-701. PMID 8993463 DOI: 10.1111/J.1749-6632.1996.Tb17543.X |
0.334 |
|
| 2005 |
Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. British Journal of Pharmacology. 146: 1069-81. PMID 16231000 DOI: 10.1038/Sj.Bjp.0706425 |
0.39 |
|
| 2005 |
Bourgault S, Létourneau M, Fournier A. Development and pharmacological characterization of "caged" urotensin II analogs. Peptides. 26: 1475-80. PMID 16042988 DOI: 10.1016/J.Peptides.2005.03.019 |
0.347 |
|
| 2005 |
Langlois C, Létourneau M, Turcotte K, Detheux M, Fournier A. PTHrP fragments 1-16 and 1-23 do not bind to either the ETA or the ETB endothelin receptors Peptides. 26: 1436-1440. PMID 16042983 DOI: 10.1016/J.Peptides.2005.03.017 |
0.409 |
|
| 2005 |
Dumont Y, Moyse E, Fournier A, Quirion R. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 315: 99-108. PMID 15947033 DOI: 10.1124/Jpet.105.089300 |
0.41 |
|
| 2005 |
Tessier S, Boivin S, Aubin J, Lampron P, Detheux M, Fournier A. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. Biochemistry. 44: 7844-54. PMID 15909998 DOI: 10.1021/Bi0500933 |
0.397 |
|
| 2005 |
Thuau R, Guilhaudis L, Ségalas-Milazzo I, Chartrel N, Oulyadi H, Boivin S, Fournier A, Leprince J, Davoust D, Vaudry H. Structural studies on 26RFa, a novel human RFamide-related peptide with orexigenic activity. Peptides. 26: 779-89. PMID 15808908 DOI: 10.1016/J.Peptides.2005.01.006 |
0.38 |
|
| 2005 |
Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, De Léan A. Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model. Biochemistry. 44: 2397-408. PMID 15709752 DOI: 10.1021/Bi048251Y |
0.435 |
|
| 2005 |
Falluel-Morel A, Vaudry D, Aubert N, Galas L, Benard M, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proceedings of the National Academy of Sciences of the United States of America. 102: 2637-42. PMID 15695581 DOI: 10.1073/Pnas.0409681102 |
0.318 |
|
| 2005 |
Deschênes J, Duperé C, McNicoll N, L'Heureux N, Auger F, Fournier A, De Léan A. Development of a selective peptide antagonist for the human natriuretic peptide receptor-B. Peptides. 26: 517-24. PMID 15652659 DOI: 10.1016/J.Peptides.2004.10.017 |
0.368 |
|
| 2005 |
Delarue C, Jouet IR, Gras M, Galas L, Fournier A, Vaudry H. Activation of endothelinA receptors in frog adrenocortical cells stimulates both calcium mobilization from intracellular stores and calcium influx through L-type calcium channels. Endocrinology. 146: 119-29. PMID 15388647 DOI: 10.1210/En.2004-0651 |
0.327 |
|
| 2004 |
Falluel-Morel A, Aubert N, Vaudry D, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. Journal of Neurochemistry. 91: 1231-43. PMID 15569266 DOI: 10.1111/J.1471-4159.2004.02810.X |
0.303 |
|
| 2004 |
Vaudry D, Cottet-Rousselle C, Basille M, Falluel-Morel A, Fournier A, Vaudry H, Gonzalez BJ. Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis. Regulatory Peptides. 123: 43-9. PMID 15518892 DOI: 10.1016/J.Regpep.2004.05.025 |
0.315 |
|
| 2004 |
Boivin S, Tessier S, Aubin J, Lampron P, Detheux M, Fournier A. Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe. Biochemistry. 43: 11516-25. PMID 15350137 DOI: 10.1021/Bi049246X |
0.389 |
|
| 2004 |
Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Neuropeptides. 38: 163-74. PMID 15337369 DOI: 10.1016/J.Npep.2004.04.007 |
0.398 |
|
| 2004 |
Mei YA, Vaudry D, Basille M, Castel H, Fournier A, Vaudry H, Gonzalez BJ. PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP. The European Journal of Neuroscience. 19: 1446-58. PMID 15066141 DOI: 10.1111/J.1460-9568.2004.03227.X |
0.319 |
|
| 2004 |
Delarue C, Conlon J, Remy-Jouet I, Fournier A, Vaudry H. Endothelins as local activators of adrenocortical cells. Journal of Molecular Endocrinology. 32: 1-7. PMID 14765988 DOI: 10.1677/Jme.0.0320001 |
0.379 |
|
| 2003 |
Juaneda C, Dumont Y, Chabot JG, Fournier A, Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues. European Journal of Pharmacology. 474: 165-74. PMID 12921858 DOI: 10.1016/S0014-2999(03)02042-9 |
0.36 |
|
| 2003 |
Villemure M, Fournier A, Gauthier D, Rabah N, Wilkes BC, Lazure C. Barley serine proteinase inhibitor 2-derived cyclic peptides as potent and selective inhibitors of convertases PC1/3 and furin. Biochemistry. 42: 9659-68. PMID 12911307 DOI: 10.1021/Bi034418W |
0.376 |
|
| 2003 |
Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. British Journal of Pharmacology. 139: 1360-8. PMID 12890716 DOI: 10.1038/Sj.Bjp.0705376 |
0.399 |
|
| 2003 |
Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, Quirion R. Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. British Journal of Pharmacology. 139: 695-704. PMID 12812992 DOI: 10.1038/Sj.Bjp.0705306 |
0.412 |
|
| 2003 |
Brkovic A, Hattenberger A, Kostenis E, Klabunde T, Flohr S, Kurz M, Bourgault S, Fournier A. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. The Journal of Pharmacology and Experimental Therapeutics. 306: 1200-9. PMID 12807997 DOI: 10.1124/Jpet.103.052415 |
0.424 |
|
| 2003 |
Langlois C, Létourneau M, Lampron P, St-Hilaire V, Fournier A. Development of agonists of endothelin-1 exhibiting selectivity towards ET A receptors British Journal of Pharmacology. 139: 616-622. PMID 12788821 DOI: 10.1038/Sj.Bjp.0705252 |
0.416 |
|
| 2003 |
Grumolato L, Elkahloun AG, Ghzili H, Alexandre D, Coulouarn C, Yon L, Salier JP, Eiden LE, Fournier A, Vaudry H, Anouar Y. Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology. 144: 2368-79. PMID 12746297 DOI: 10.1210/En.2002-0106 |
0.316 |
|
| 2003 |
Rodi D, Mazzuferi M, Bregola G, Dumont Y, Fournier A, Quirion R, Simonato M. Changes in NPY-mediated modulation of hippocampal [3H]D-aspartate outflow in the kindling model of epilepsy. Synapse (New York, N.Y.). 49: 116-24. PMID 12740867 DOI: 10.1002/Syn.10216 |
0.354 |
|
| 2003 |
Jacques D, Sader S, Perreault C, Fournier A, Pelletier G, Beck-Sickinger AG, Descorbeth M. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. Canadian Journal of Physiology and Pharmacology. 81: 288-300. PMID 12733827 DOI: 10.1139/Y02-165 |
0.401 |
|
| 2003 |
Vaudry D, Falluel-Morel A, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. Journal of Neuroscience Research. 72: 303-16. PMID 12692897 DOI: 10.1002/Jnr.10530 |
0.349 |
|
| 2003 |
Grumolato L, Louiset E, Alexandre D, Aït-Ali D, Turquier V, Fournier A, Fasolo A, Vaudry H, Anouar Y. PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. The European Journal of Neuroscience. 17: 71-82. PMID 12534970 DOI: 10.1046/J.1460-9568.2003.02426.X |
0.329 |
|
| 2003 |
Masmoudi O, Gandolfo P, Leprince J, Vaudry D, Fournier A, Patte-Mensah C, Vaudry H, Tonon MC. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 17-27. PMID 12522108 DOI: 10.1096/Fj.02-0317Com |
0.415 |
|
| 2003 |
Payet MD, Bilodeau L, Breault L, Fournier A, Yon L, Vaudry H, Gallo-Payet N. PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells. The Journal of Biological Chemistry. 278: 1663-70. PMID 12429744 DOI: 10.1074/Jbc.M206470200 |
0.336 |
|
| 2002 |
Turquier V, Yon L, Grumolato L, Alexandre D, Fournier A, Vaudry H, Anouar Y. Pituitary adenylate cyclase--activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells. Annals of the New York Academy of Sciences. 971: 471-3. PMID 12438167 DOI: 10.1111/J.1749-6632.2002.Tb04511.X |
0.309 |
|
| 2002 |
Tostivint H, Vieau D, Chartrel N, Boutelet I, Galas L, Fournier A, Lihrmann I, Vaudry H. Expression and processing of the [Pro(2),Met(13)]somatostatin-14 precursor in the intermediate lobe of the frog pituitary. Endocrinology. 143: 3472-81. PMID 12193560 DOI: 10.1210/En.2002-220406 |
0.366 |
|
| 2002 |
Alexandre D, Vaudry H, Grumolato L, Turquier V, Fournier A, Jégou S, Anouar Y. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance. Endocrinology. 143: 2680-92. PMID 12072402 DOI: 10.1210/Endo.143.7.8880 |
0.336 |
|
| 2002 |
Vaudry D, Pamantung TF, Basille M, Rousselle C, Fournier A, Vaudry H, Beauvillain JC, Gonzalez BJ. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. The European Journal of Neuroscience. 15: 1451-60. PMID 12028355 DOI: 10.1046/J.1460-9568.2002.01981.X |
0.322 |
|
| 2002 |
Vaudry D, Rousselle C, Basille M, Falluel-Morel A, Pamantung TF, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proceedings of the National Academy of Sciences of the United States of America. 99: 6398-403. PMID 11972030 DOI: 10.1073/Pnas.082112699 |
0.305 |
|
| 2002 |
Beaujean D, Do-Rego JL, Galas L, Mensah-Nyagan AG, Fredriksson R, Larhammar D, Fournier A, Luu-The V, Pelletier G, Vaudry H. Neuropeptide Y inhibits the biosynthesis of sulfated neurosteroids in the hypothalamus through activation of Y(1) receptors. Endocrinology. 143: 1950-63. PMID 11956178 DOI: 10.1210/Endo.143.5.8765 |
0.368 |
|
| 2002 |
Galas L, Tonon MC, Beaujean D, Fredriksson R, Larhammar D, Lihrmann I, Jegou S, Fournier A, Chartrel N, Vaudry H. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells. Endocrinology. 143: 1686-94. PMID 11956150 DOI: 10.1210/Endo.143.5.8761 |
0.351 |
|
| 2002 |
Donoso MV, Brown N, Carrasco C, Cortes V, Fournier A, Huidobro-Toro JP. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. Journal of Neurochemistry. 69: 1048-1059. PMID 9282927 DOI: 10.1046/J.1471-4159.1997.69031048.X |
0.349 |
|
| 2001 |
Wang Y, Jensen J, Abel PW, Fournier A, Holmgren S, Conlon JM. Effects of trout endothelin on the motility of gastrointestinal smooth muscle from the trout and rat. General and Comparative Endocrinology. 123: 156-162. PMID 11482936 DOI: 10.1006/Gcen.2001.7658 |
0.322 |
|
| 2001 |
Yon L, Alexandre D, Montéro M, Chartrel N, Jeandel L, Vallarino M, Conlon JM, Kikuyama S, Fournier A, Gracia-Navarro F, Roubos E, Chow B, Arimura A, Anouar Y, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians. Microscopy Research and Technique. 54: 137-57. PMID 11458398 DOI: 10.1002/Jemt.1129 |
0.423 |
|
| 2001 |
Cartier F, Do-Rego J, Remy-Jouet I, Fournier A, Vaudry H, Delarue C. Evidence for the involvement of nitric oxide in the control of steroid secretion by the frog adrenal gland. The Journal of Steroid Biochemistry and Molecular Biology. 77: 251-259. PMID 11457663 DOI: 10.1016/S0960-0760(01)00063-2 |
0.339 |
|
| 2001 |
Turquier V, Yon L, Grumolato L, Alexandre D, Fournier A, Vaudry H, Anouar Y. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors. Molecular Pharmacology. 60: 42-52. PMID 11408599 DOI: 10.1124/Mol.60.1.42 |
0.388 |
|
| 2001 |
Mathieu M, Yon L, Charifou I, Trabucchi M, Vallarino M, Pinelli C, Fournier A, Rastogi RK, Vaudry H. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) in the frog (Rana ridibunda) tadpole brain: immunohistochemical localization and biochemical characterization. The Journal of Comparative Neurology. 431: 11-27. PMID 11169987 DOI: 10.1002/1096-9861(20010226)431:1<11::Aid-Cne1052>3.0.Co;2-J |
0.325 |
|
| 2000 |
Breault L, Yon L, Montéro M, Chouinard L, Contesse V, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N. Occurrence and effect of PACAP in the human fetal adrenal gland Annals of the New York Academy of Sciences. 921: 429-433. PMID 11193870 DOI: 10.1111/J.1749-6632.2000.Tb07010.X |
0.347 |
|
| 2000 |
Basille M, Vaudry D, Coulouarn Y, Jégou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez BJ. Distribution of PACAP receptor mRNAs and PACAP binding sites in the rat brain during development. Annals of the New York Academy of Sciences. 921: 304-7. PMID 11193840 DOI: 10.1111/J.1749-6632.2000.Tb06982.X |
0.343 |
|
| 2000 |
Alexandre D, Anouar Y, Jégou S, Fournier A, Vaudry H. Molecular cloning, mRNA distribution and pharmacological characterization of a VIP/PACAP receptor in the frog Rana ridibunda. Annals of the New York Academy of Sciences. 921: 300-3. PMID 11193839 DOI: 10.1111/J.1749-6632.2000.Tb06981.X |
0.324 |
|
| 2000 |
Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fournier A, Vaudry H. PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex. Annals of the New York Academy of Sciences. 921: 293-9. PMID 11193838 DOI: 10.1111/J.1749-6632.2000.Tb06980.X |
0.335 |
|
| 2000 |
Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proceedings of the National Academy of Sciences of the United States of America. 97: 13390-5. PMID 11087878 DOI: 10.1073/Pnas.97.24.13390 |
0.341 |
|
| 2000 |
Langlois C, Tessier S, Brkovic A, Fournier A. An improved procedure for the preparation of the endothelin-B-receptor ligand sarafotoxin 6c. Journal of Cardiovascular Pharmacology. 36: S290-1. PMID 11078401 DOI: 10.1097/00005344-200036051-00085 |
0.39 |
|
| 2000 |
Tessier S, Langlois C, Brkovic A, Coupal M, De Léan A, Fournier A. Development of a photolabile ligand for the endothelin-A receptor of endothelin. Journal of Cardiovascular Pharmacology. 36: S53-4. PMID 11078334 DOI: 10.1097/00005344-200036051-00018 |
0.372 |
|
| 2000 |
Khiat A, Fournier A, Lubell W, Boulanger Y. Conformational analysis of endothelin-1 analogs with indolizidinone amino acids incorporated at the C-terminus. Journal of Cardiovascular Pharmacology. 36. PMID 11078329 DOI: 10.1097/00005344-200036051-00013 |
0.541 |
|
| 2000 |
Létourneau M, Roby P, Tremblay F, Carette J, Fournier A. New short peptide substrates of endothelin-converting enzyme and characterization of the enzyme. Journal of Cardiovascular Pharmacology. 36: S28-9. PMID 11078327 DOI: 10.1097/00005344-200036051-00011 |
0.35 |
|
| 2000 |
Parker MS, Wang JJ, Fournier A, Parker SL. Upregulation of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors in estrogen-induced hypertrophy of the anterior pituitary gland in the Fischer-344 rat Molecular and Cellular Endocrinology. 164: 239-249. PMID 11026575 DOI: 10.1016/S0303-7207(00)00195-7 |
0.377 |
|
| 2000 |
Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. The Journal of Comparative Neurology. 425: 495-509. PMID 10975876 DOI: 10.1002/1096-9861(20001002)425:4<495::Aid-Cne3>3.0.Co;2-A |
0.321 |
|
| 2000 |
Bregola G, Dumont Y, Fournier A, Zucchini S, Quirion R, Simonato M. Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy. Neuroscience. 98: 697-703. PMID 10891613 DOI: 10.1016/S0306-4522(00)00162-7 |
0.349 |
|
| 2000 |
Yu MWN, Scott JK, Fournier A, Talbot PJ. Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides Virology. 271: 182-196. PMID 10814583 DOI: 10.1006/Viro.2000.0310 |
0.332 |
|
| 2000 |
Wang Y, Remy-Jouet I, Delarue C, Letourneau M, Fournier A, Vaudry H, Conlon J. Structural characterization and effects on corticosteroid secretion of endothelin-1 and endothelin-3 from the frog Rana ridibunda Journal of Molecular Endocrinology. 24: 285-293. PMID 10750029 DOI: 10.1677/Jme.0.0240285 |
0.35 |
|
| 2000 |
Dumont Y, Cadieux A, Doods H, Fournier A, Quirion R. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO3304 (Y1) and CGP71683A (Y5) Canadian Journal of Physiology and Pharmacology. 78: 116-125. DOI: 10.1139/Y99-119 |
0.41 |
|
| 2000 |
Fournier A, Létourneau M. Modified fragments of endothelin active in an ET-A receptor bioassay Regulatory Peptides. 94: 46. DOI: 10.1016/S0167-0115(00)80092-0 |
0.376 |
|
| 1999 |
Jeandel L, Yon L, Chartrel N, Gonzalez B, Fournier A, Conlon JM, Vaudry H. Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda. The Journal of Comparative Neurology. 412: 218-28. PMID 10441752 DOI: 10.1002/(Sici)1096-9861(19990920)412:2<218::Aid-Cne3>3.0.Co;2-L |
0.384 |
|
| 1999 |
Zouki C, Baron C, Fournier A, Filep JG. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ETA receptors and platelet-activating factor British Journal of Pharmacology. 127: 969-979. PMID 10433505 DOI: 10.1038/Sj.Bjp.0702593 |
0.383 |
|
| 1999 |
Vaudry D, Gonzalez BJ, Basille M, Fournier A, Vaudry H. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proceedings of the National Academy of Sciences of the United States of America. 96: 9415-20. PMID 10430957 DOI: 10.1073/Pnas.96.16.9415 |
0.346 |
|
| 1999 |
Coupal M, Léan AD, McNicoll N, Fournier A. Development of p-benzoylbenzoylated [N,C,rANP(1-28)]pBNP32 (pBNP1) derivatives and affinity photolabeling of the bovine NPR-A receptor. Biochemical and Biophysical Research Communications. 258: 81-86. PMID 10222239 DOI: 10.1006/Bbrc.1999.0597 |
0.344 |
|
| 1999 |
Cartier F, Delarue C, Remy-Jouet I, Kodjo MK, Fournier A, Vaudry H. The stimulatory effect of endothelin-1 on frog adrenocortical cells is mediated through both the phospholipase C and the adenylyl cyclase transduction pathways. Molecular and Cellular Endocrinology. 147: 27-36. PMID 10195689 DOI: 10.1016/S0303-7207(98)00223-8 |
0.387 |
|
| 1999 |
Boulanger Y, Biron E, Khiat A, Fournier A. Conformational analysis of biologically active truncated linear analogs of endothelin-1 using NMR and molecular modeling Journal of Peptide Research. 53: 214-222. PMID 10195458 DOI: 10.1034/J.1399-3011.1999.00022.X |
0.327 |
|
| 1999 |
Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Endocrinology. 140: 1285-93. PMID 10067855 DOI: 10.1210/Endo.140.3.6576 |
0.394 |
|
| 1999 |
Hong M, Yon L, Fournier A, Vaudry H, Pelletier G. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on tyrosine hydroxylase gene expression in the rat adrenal medulla. Annals of the New York Academy of Sciences. 865: 478-81. PMID 9928054 DOI: 10.1111/J.1749-6632.1998.Tb11220.X |
0.328 |
|
| 1999 |
Montero M, Yon L, Rousseau K, Arimura A, Fournier A, Dufour S, Vaudry H. Localization of pituitary adenylate cyclase-activating polypeptide in the central nervous system of the European eel Anguilla anguilla: stimulatory effect of PACAP on GH secretion. Annals of the New York Academy of Sciences. 865: 475-7. PMID 9928053 DOI: 10.1111/J.1749-6632.1998.Tb11219.X |
0.318 |
|
| 1999 |
Cadieux A, Monast NP, Pomerleau F, Fournier A, Lanoue C. Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways. Effect of pulmonary inflammation. American Journal of Respiratory and Critical Care Medicine. 159: 235-43. PMID 9872844 DOI: 10.1164/Ajrccm.159.1.9711031 |
0.338 |
|
| 1998 |
Montero M, Yon L, Rousseau K, Arimura A, Fournier A, Dufour S, Vaudry H. Distribution, Characterization, and Growth Hormone-Releasing Activity of Pituitary Adenylate Cyclase-Activating Polypeptide in the European Eel, Anguilla anguilla* * This work was supported by grants from INSERM U-413, the Conseil Supérieur de la Pêche, and the Conseil Régional de Haute-Normandie. Endocrinology. 139: 4300-4310. PMID 28200229 DOI: 10.1210/Endo.139.10.6239 |
0.327 |
|
| 1998 |
Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Gallo-Payet N, Vaudry H. Pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland Annals of the New York Academy of Sciences. 865: 416-419. PMID 9928041 DOI: 10.1111/J.1749-6632.1998.Tb11207.X |
0.374 |
|
| 1998 |
Vaudry D, Basille M, Anouar Y, Fournier A, Vaudry H, Gonzalez BJ. The neurotrophic activity of PACAP on rat cerebellar granule cells is associated with activation of the protein kinase A pathway and c-fos gene expression. Annals of the New York Academy of Sciences. 865: 92-9. PMID 9928001 DOI: 10.1111/J.1749-6632.1998.Tb11167.X |
0.342 |
|
| 1998 |
Breault L, Yon L, Montéro M, Contesse V, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N. Presence of PACAP and PACAP receptors in the human adrenal gland: Possible role in fetal development Endocrine Research. 24: 961-962. PMID 9888606 DOI: 10.3109/07435809809032716 |
0.35 |
|
| 1998 |
Yon L, Montero M, Bellancourt G, Fournier A, Chartrel N, Vaudry H. Involvement of pituitary adenylate cyclase-activating polypeptide in the regulation of frog adrenal steroidogenesis. Annals of the New York Academy of Sciences. 839: 384-5. PMID 9629184 DOI: 10.1111/J.1749-6632.1998.Tb10806.X |
0.33 |
|
| 1998 |
Esneu M, Delarue C, Fournier A, Conlon JM, Vaudry H. Neuroendocrine control of frog adrenocortical cells by calcitonin gene-related peptide. Annals of the New York Academy of Sciences. 839: 382-3. PMID 9629183 DOI: 10.1111/J.1749-6632.1998.Tb10805.X |
0.328 |
|
| 1998 |
Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience. 84: 801-12. PMID 9579785 DOI: 10.1016/S0306-4522(97)00545-9 |
0.359 |
|
| 1998 |
Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N. Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation Journal of Clinical Endocrinology and Metabolism. 83: 1299-1305. PMID 9543159 DOI: 10.1210/Jcem.83.4.4690 |
0.366 |
|
| 1998 |
Grinevich V, Fournier A, Pelletier G. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Research. 773: 190-6. PMID 9409720 DOI: 10.1016/S0006-8993(97)01011-1 |
0.402 |
|
| 1998 |
Dumont Y, Fournier A, Quirion R. Expression and Characterization of the Neuropeptide Y Y5Receptor Subtype in the Rat Brain The Journal of Neuroscience. 18: 5565-5574. DOI: 10.1523/Jneurosci.18-15-05565.1998 |
0.412 |
|
| 1998 |
GONZALEZ BJ, BASILLE M, VAUDRY D, FOURNIER A, CAZIN L, VAUDRY H. Neurotrophic Activity of Pituitary Adenylate Cyclase-Activating Polypeptidea Annals of the New York Academy of Sciences. 839: 551-552. DOI: 10.1111/J.1749-6632.1998.Tb10869.X |
0.306 |
|
| 1997 |
Delarue C, Esneu M, Fournier A, Vaudry H. Role of the cytoskeleton in the secretory response of the frog adrenal gland to calcitonin gene-related peptide The Journal of Steroid Biochemistry and Molecular Biology. 63: 21-27. PMID 9449202 DOI: 10.1016/S0960-0760(97)00067-8 |
0.341 |
|
| 1997 |
Cartier F, Remy-Jouet I, Fournier A, Vaudry H, Delarue C. Effect of endothelin-1 on corticosteroid secretion by the frog adrenal gland is mediated by an endothelinA receptor. Endocrinology. 138: 4358-63. PMID 9322951 DOI: 10.1210/Endo.138.10.5448 |
0.347 |
|
| 1997 |
Pheng LH, Quirion R, Iyengar S, Fournier A, Regoli D. The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor. European Journal of Pharmacology. 333: R3-5. PMID 9314048 DOI: 10.1016/S0014-2999(97)01161-8 |
0.398 |
|
| 1997 |
Pomerleau F, Fournier A, Cadieux A. Mouse aorta: a preparation highly sensitive to the vasodilatory action of CGRP. Journal of Cardiovascular Pharmacology. 30: 343-351. PMID 9300319 DOI: 10.1097/00005344-199709000-00012 |
0.361 |
|
| 1997 |
Labelle M, Boulanger Y, Fournier A, St Pierre S, Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides. 18: 801-8. PMID 9285928 DOI: 10.1016/S0196-9781(97)00028-4 |
0.356 |
|
| 1997 |
Carpenter KA, Wilkes BC, De Léan A, Fournier A, Schiller PW. Hydrophobic forces are responsible for the folding of a highly potent natriuretic peptide analogue at a membrane mimetic surface: an NMR study. Biopolymers. 42: 37-48. PMID 9209157 DOI: 10.1002/(Sici)1097-0282(199707)42:1<37::Aid-Bip4>3.0.Co;2-2 |
0.346 |
|
| 1997 |
Pheng LH, Fournier A, Dumont Y, Quirion R, Regoli D. The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y. European Journal of Pharmacology. 327: 163-7. PMID 9200555 DOI: 10.1016/S0014-2999(97)89656-2 |
0.409 |
|
| 1997 |
Jacques D, Dumont Y, Fournier A, Quirion R. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience. 79: 129-48. PMID 9178870 DOI: 10.1016/S0306-4522(96)00639-2 |
0.397 |
|
| 1997 |
Gonzalez BJ, Basille M, Vaudry D, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience. 78: 419-30. PMID 9145799 DOI: 10.1016/S0306-4522(96)00617-3 |
0.355 |
|
| 1997 |
Esneu M, Delarue C, Fournier A, Vaudry H. Characterization of the receptor mediating the effect of calcitonin gene-related peptide in the frog adrenal gland. European Journal of Pharmacology. 308: 187-93. PMID 8840131 DOI: 10.1016/0014-2999(96)00295-6 |
0.434 |
|
| 1997 |
Gonzalez B, Vaudry D, Basille M, Fournier A, Vaudry H. Rôle neurotrophique potentiel du pituitary adenylate cyclase-activating polypeptide. M S-Medecine Sciences. 13: 1331-1335. DOI: 10.4267/10608/554 |
0.331 |
|
| 1997 |
Lewis K, D'Orleans-Juste P, Benchekroun MT, Fournier A, Cadieux A. Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung Canadian Journal of Physiology and Pharmacology. 75: 677-689. DOI: 10.1139/Y97-046 |
0.355 |
|
| 1996 |
Gonzalez BJ, Basille M, Mei YA, Vaudry D, Fournier A, Cazin L, Vaudry H. Ontogeny of PACAP and PACAP receptors in the rat brain: role of PACAP in the cerebellum during development. Annals of the New York Academy of Sciences. 805: 302-13; discussion 3. PMID 8993412 DOI: 10.1111/J.1749-6632.1996.Tb17492.X |
0.346 |
|
| 1996 |
Donoso MV, Faundez H, Rosa G, Fournier A, Edvinsson L, Huidobro-Toro JP. Pharmacological characterization of the ET(A) receptor in the vascular smooth muscle comparing its analogous distribution in the rat mesenteric artery and in the arterial mesenteric bed Peptides. 17: 1145-1153. PMID 8959749 DOI: 10.1016/S0196-9781(96)00188-X |
0.316 |
|
| 1996 |
Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: Exclusive role of ET(B) receptors Journal of Applied Physiology. 81: 1510-1515. PMID 8904561 DOI: 10.1152/Jappl.1996.81.4.1510 |
0.315 |
|
| 1996 |
Tostivint H, Lihrmann I, Bucharles C, Vieau D, Coulouarn Y, Fournier A, Conlon JM, Vaudry H. Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides. Proceedings of the National Academy of Sciences of the United States of America. 93: 12605-10. PMID 8901629 DOI: 10.1073/Pnas.93.22.12605 |
0.362 |
|
| 1996 |
Li S, Grinevich V, Fournier A, Pelletier G. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain Molecular Brain Research. 41: 157-162. PMID 8883947 DOI: 10.1016/0169-328X(96)00086-1 |
0.406 |
|
| 1996 |
Boulanger Y, Khiat A, Larocque A, Fournier A, St-Pierre S. Structural comparison of alanine-substituted analogues of the calcitonin gene-related peptide 8-37: Importance of the C-terminal segment for antagonistic activity International Journal of Peptide and Protein Research. 47: 477-483. PMID 8836775 DOI: 10.1111/J.1399-3011.1996.Tb01098.X |
0.366 |
|
| 1996 |
Filep JG, Skrobik Y, Fournier A, Földes-Filep É. Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat. British Journal of Pharmacology. 118: 893-900. PMID 8799559 DOI: 10.1111/J.1476-5381.1996.Tb15483.X |
0.337 |
|
| 1996 |
Dumont Y, Fournier A, St-Pierre S, Quirion R. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse (New York, N.Y.). 22: 139-58. PMID 8787130 DOI: 10.1002/(Sici)1098-2396(199602)22:2<139::Aid-Syn7>3.0.Co;2-E |
0.376 |
|
| 1996 |
Bodart V, Rainey WE, Fournier A, Ong H, De Léan A. The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis Molecular and Cellular Endocrinology. 118: 137-144. PMID 8735599 DOI: 10.1016/0303-7207(96)03776-8 |
0.443 |
|
| 1995 |
Forget MA, Lebel N, Sirois P, Boulanger Y, Battistini B, Fournier A. Structure-activity studies of the C-terminal segment of structurally reduced analogues of ET-1 Journal of Cardiovascular Pharmacology. 26: S107-S110. PMID 8587333 DOI: 10.1097/00005344-199506263-00033 |
0.346 |
|
| 1995 |
Bernier SG, Servant G, Boudreau M, Fournier A, Guillemette G. Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. European Journal of Pharmacology. 291: 191-200. PMID 8566170 DOI: 10.1016/0922-4106(95)90142-6 |
0.347 |
|
| 1995 |
Filep JG, Fournier A, Földes-Filep É. Effects of the ETA/ETB receptor antagonist, bosentan on endothelin‐1‐induced myocardial ischaemia and oedema in the rat British Journal of Pharmacology. 116: 1745-1750. PMID 8528554 DOI: 10.1111/J.1476-5381.1995.Tb16657.X |
0.371 |
|
| 1995 |
Filep JG, Clozel M, Fournier A, Földes-Filep E. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. British Journal of Pharmacology. 113: 845-52. PMID 7858876 DOI: 10.1111/J.1476-5381.1994.Tb17070.X |
0.385 |
|
| 1995 |
Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. Brain Research. Molecular Brain Research. 26: 320-4. PMID 7854062 DOI: 10.1016/0169-328X(94)90105-8 |
0.431 |
|
| 1995 |
Mimeault M, Lean AD, Lafleur M, Bonenfant D, Fournier A. Evaluation Of Conformational And Binding Characteristics Of Various Natriuretic Peptides And Related Analogs Biochemistry. 34: 955-964. PMID 7827054 DOI: 10.1021/Bi00003A030 |
0.352 |
|
| 1995 |
Boulanger Y, Chen Y, Commodari F, Senecal L, Laberge AM, Fournier A, St-Pierre S. Structural characterizations of neuropeptide tyrosine (NPY) and its agonist analog [Ahx5-17]NPY by NMR and molecular modeling International Journal of Peptide and Protein Research. 45: 86-95. PMID 7775012 DOI: 10.1111/J.1399-3011.1995.Tb01571.X |
0.357 |
|
| 1995 |
Yebenes EGd, Li S, Fournier A, St-Pierre S, Pelletier G. Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus Brain Research. 674: 112-116. PMID 7773678 DOI: 10.1016/0006-8993(94)01429-L |
0.402 |
|
| 1995 |
Perez-Vizcaino F, Cooper AC, Corder R, Fournier A, Warner TD. Rapid degradation of endothelin-1 by an enzyme released by the rat isolated perfused mesentery British Journal of Pharmacology. 114: 867-871. PMID 7773548 DOI: 10.1111/J.1476-5381.1995.Tb13284.X |
0.307 |
|
| 1995 |
Bouali SM, Fournier A, Jolicoeur FB. Differential effects of pertussis toxin on body temperature changes induced by neuropeptide Y and NPY2-36. Regulatory Peptides. 54: 367-72. PMID 7716271 DOI: 10.1016/0167-0115(94)90534-7 |
0.346 |
|
| 1995 |
Filep JG, Fournier A, Földes-Filep É. Acute pro‐inflammatory actions of endothelin‐1 in the guinea‐pig lung: involvement of ETA and ETB receptors British Journal of Pharmacology. 115: 227-236. PMID 7670725 DOI: 10.1111/J.1476-5381.1995.Tb15868.X |
0.385 |
|
| 1995 |
Yebenes EGd, Li S, Fournier A, St-Pierre S, Pelletier G. Involvement of the Y2 receptor subtype in the regulation of prolactin gene expression by neuropeptide Y in the male rat. Neuroscience Letters. 190: 77-80. PMID 7644126 DOI: 10.1016/0304-3940(95)11505-Q |
0.416 |
|
| 1995 |
Basille M, Gonzalez BJ, Desrues L, Demas M, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts. Journal of Neurochemistry. 65: 1318-24. PMID 7643109 DOI: 10.1046/J.1471-4159.1995.65031318.X |
0.402 |
|
| 1995 |
Jolicoeur FB, Bouali SM, Michaud JN, Ménard D, Fournier A, St-Pierre S. Structure-activity analysis of the motor effects of neuropeptide Y. Brain Research Bulletin. 37: 1-4. PMID 7606474 DOI: 10.1016/0361-9230(94)00172-3 |
0.327 |
|
| 1995 |
Battistini B, Woods M, O'Donnell LJD, Warner TD, Corder R, Fournier A, Farthing MJG, Vane JR. Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme British Journal of Pharmacology. 114: 1383-1390. PMID 7606342 DOI: 10.1111/J.1476-5381.1995.Tb13359.X |
0.302 |
|
| 1994 |
Yon L, Feuilloley M, Chartrel N, Arimura A, Fournier A, Vaudry H. Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland. The Journal of Endocrinology. 139: 183-94. PMID 8308455 DOI: 10.1677/Joe.0.1390183 |
0.415 |
|
| 1994 |
Battistini B, Warner TD, Fournier A, Vane JR. Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620 European Journal of Pharmacology. 252: 341-345. PMID 8162956 DOI: 10.1016/0014-2999(94)90184-8 |
0.332 |
|
| 1994 |
Battistini B, Warner TD, Fournier A, Vane JR. Characterization of ET(B) receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: Effects of BQ-123, FR139317 or PD 145065 British Journal of Pharmacology. 111: 1009-1116. PMID 8032583 DOI: 10.1111/J.1476-5381.1994.Tb14844.X |
0.301 |
|
| 1994 |
Esneu M, Delarue C, Remy-Jouet I, Manzardo E, Fasolo A, Fournier A, Saint-Pierre S, Conlon JM, Vaudry H. Localization, identification, and action of calcitonin gene-related peptide in the frog adrenal gland. Endocrinology. 135: 423-30. PMID 8013380 DOI: 10.1210/Endo.135.1.8013380 |
0.358 |
|
| 1994 |
Donoso MV, Salas C, Sepúlveda G, Lewin J, Fournier A, Huidobro-Toro JP. Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder. British Journal of Pharmacology. 111: 473-82. PMID 8004392 DOI: 10.1111/J.1476-5381.1994.Tb14761.X |
0.34 |
|
| 1994 |
Bouali SM, Fournier A, St-Pierre S, Jolicoeur FB. In vivo central actions of NPY(1-30), an N-terminal fragment of neuropeptide Y Peptides. 15: 799-802. PMID 7984497 DOI: 10.1016/0196-9781(94)90032-9 |
0.382 |
|
| 1994 |
Filep JG, Fournier A, Földes-Filep É. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2 British Journal of Pharmacology. 112: 963-971. PMID 7921626 DOI: 10.1111/J.1476-5381.1994.Tb13175.X |
0.348 |
|
| 1994 |
Li S, Hong M, Fournier A, St-Pierre S, Pelletier G. Role of neuropeptide Y in the regulation of gonadotropin-releasing hormone gene expression in the rat preoptic area Molecular Brain Research. 26: 69-73. PMID 7854068 DOI: 10.1016/0169-328X(94)90075-2 |
0.432 |
|
| 1994 |
Basille M, Gonzalez BJ, Fournier A, Vaudry H. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study. Brain Research. Developmental Brain Research. 82: 81-9. PMID 7842522 DOI: 10.1016/0165-3806(94)90150-3 |
0.321 |
|
| 1994 |
Drumheller A, Bouali SM, Fournier A, St-Pierre S, Jolicoeur FB. Neurochemical effects of neuropeptide Y (NPY) and NPY2-36 Neuropeptides. 27: 291-296. PMID 7532289 DOI: 10.1016/0143-4179(94)90110-4 |
0.342 |
|
| 1993 |
Mimeault M, St‐Pierre S, Fournier A. Conformational characterization by circular-dichroism spectroscopy of various fragments and analogs of calcitonin-gene-related peptide Febs Journal. 213: 927-934. PMID 8504832 DOI: 10.1111/J.1432-1033.1993.Tb17837.X |
0.333 |
|
| 1993 |
Donoso MV, Boric M, Prado M, Fournier A, Pierre SS, Edvinsson L, Huidobro-Toro JP. D-myo-Inositol 1,2,6-triphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bed European Journal of Pharmacology. 240: 93-97. PMID 8405129 DOI: 10.1016/0014-2999(93)90552-S |
0.327 |
|
| 1993 |
Dumont Y, Satoh H, Cadieux A, Taoudi-Benchekroun M, Pheng LH, St-Pierre S, Fournier A, Quirion R. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types. European Journal of Pharmacology. 238: 37-45. PMID 8405081 DOI: 10.1016/0014-2999(93)90502-9 |
0.399 |
|
| 1993 |
Yon L, Jeandel L, Chartrel N, Feuilloley M, Conlon JM, Arimura A, Fournier A, Vaudry H. Neuroanatomical and physiological evidence for the involvement of pituitary adenylate cyclase-activating polypeptide in the regulation of the distal lobe of the frog pituitary. Journal of Neuroendocrinology. 5: 289-96. PMID 8391365 DOI: 10.1111/J.1365-2826.1993.Tb00485.X |
0.392 |
|
| 1993 |
Fournier A, Couvineau A, Laburthe M. Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor. Analytical Biochemistry. 211: 305-10. PMID 8391225 DOI: 10.1006/Abio.1993.1274 |
0.383 |
|
| 1993 |
Poitras M, Bernier S, Boulay G, Fournier A, Guillemette G. Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes. European Journal of Pharmacology. 244: 203-10. PMID 8384566 DOI: 10.1016/0922-4106(93)90145-Y |
0.367 |
|
| 1993 |
Filep JG, Sirois MG, Földes-Filep E, Rousseau A, Plante GE, Fournier A, Yano M, Sirois P. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. British Journal of Pharmacology. 109: 880-6. PMID 8358577 DOI: 10.1111/J.1476-5381.1993.Tb13657.X |
0.382 |
|
| 1993 |
Germain M, Battistini B, Filep JG, Sirois P, Fournier A. Endothelin derivatives showing potent effects in the guinea pig trachea. Peptides. 14: 613-9. PMID 8332557 DOI: 10.1016/0196-9781(93)90153-8 |
0.407 |
|
| 1993 |
Cadieux A, Pheng L, St-Pierre S, Fournier A, Benchekroun MT. The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype. Regulatory Peptides. 46: 557-564. PMID 8210515 DOI: 10.1016/0167-0115(93)90257-9 |
0.443 |
|
| 1993 |
Basille M, Gonzalez BJ, Leroux P, Jeandel L, Fournier A, Vaudry H. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells. Neuroscience. 57: 329-38. PMID 8115042 DOI: 10.1016/0306-4522(93)90066-O |
0.387 |
|
| 1993 |
Chen Y, Fournier A, Couvineau A, Laburthe M, Amiranoff B. Purification of a galanin receptor from pig brain. Proceedings of the National Academy of Sciences of the United States of America. 90: 3845-9. PMID 7683410 DOI: 10.1073/Pnas.90.9.3845 |
0.376 |
|
| 1993 |
Battistini B, Germain M, Fournier A, Sirois P. Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes. Journal of Cardiovascular Pharmacology. 22. PMID 7509949 DOI: 10.1097/00005344-199322008-00059 |
0.343 |
|
| 1993 |
Blasquez C, Jégou S, Tranchand Bunel D, Fournier A, Vaudry H. Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein. Brain Research. 596: 163-8. PMID 1334775 DOI: 10.1016/0006-8993(92)91544-O |
0.327 |
|
| 1993 |
Amiranoff B, Chen Y, Fournier A, Couvineau A, Laburthe M. The brain galanin receptor: Purification by a one-step affinity chromatography Neuropeptides. 24: 243. DOI: 10.1016/0143-4179(93)90267-E |
0.335 |
|
| 1992 |
Sirois MG, Filep JG, Rousseau A, Fournier A, Plante GE, Sirois P. Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2. European Journal of Pharmacology. 214: 119-25. PMID 1516634 DOI: 10.1016/0014-2999(92)90108-G |
0.329 |
|
| 1992 |
Filep JG, Rousseau A, Fournier A, Sirois P. Structure-activity relationship of analogues of endothelin-1: dissociation of hypotensive and pressor actions. European Journal of Pharmacology. 220: 263-266. PMID 1425997 DOI: 10.1016/0014-2999(92)90757-U |
0.401 |
|
| 1992 |
Filep JG, Földes-Filep É, Rousseau A, Fournier A, Sirois P, Yano M. Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor European Journal of Pharmacology. 219: 343-344. PMID 1425961 DOI: 10.1016/0014-2999(92)90318-X |
0.35 |
|
| 1992 |
T-Benchekroun M, Fournier A, St-Pierre S, Cadieux A. Inhibitory action of neuropeptide Y on agonist-induced responses in isolated guinea pig trachea. European Journal of Pharmacology. 216: 421-428. PMID 1385164 DOI: 10.1016/0014-2999(92)90440-F |
0.357 |
|
| 1992 |
Quirion R, Van Rossum D, Dumont Y, St-Pierre S, Fournier A. Characterization of CGRP1 and CGRP2 receptor subtypes. Annals of the New York Academy of Sciences. 657: 88-105. PMID 1322107 DOI: 10.1111/J.1749-6632.1992.Tb22759.X |
0.362 |
|
| 1992 |
Lanoue C, Fournier A, St-Pierre S, Cadieux A. Characterization of CGRP receptor sites in rat airways. Annals of the New York Academy of Sciences. 657: 441-3. PMID 1322098 DOI: 10.1111/j.1749-6632.1992.tb22794.x |
0.343 |
|
| 1992 |
Mimeault M, Quirion R, Dumont Y, St-Pierre S, Fournier A. Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. Journal of Medicinal Chemistry. 35: 2163-8. PMID 1319490 DOI: 10.1021/Jm00090A003 |
0.466 |
|
| 1992 |
Kalra SP, Fuentes M, Fournier A, Parker SL, Crowley WR. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology. 130: 3323-30. PMID 1317781 DOI: 10.1210/Endo.130.6.1317781 |
0.325 |
|
| 1992 |
Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Progress in Neurobiology. 38: 125-67. PMID 1312243 DOI: 10.1016/0301-0082(92)90038-G |
0.335 |
|
| 1991 |
Quirion R, Martel JC, Dumont Y, Cadieux A, Jolicoeur F, St-Pierre S, Fournier A. Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships. Annals of the New York Academy of Sciences. 611: 58-72. PMID 2174224 DOI: 10.1111/J.1749-6632.1990.Tb48922.X |
0.35 |
|
| 1991 |
Danger JM, Breton B, Vallarino M, Fournier A, Pelletier G, Vaudry H. Neuropeptide-Y in the trout brain and pituitary: localization, characterization, and action on gonadotropin release. Endocrinology. 128: 2360-8. PMID 2019255 DOI: 10.1210/Endo-128-5-2360 |
0.355 |
|
| 1991 |
Jolicoeur FB, Michaud JN, Menard D, Fournier A. In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors Brain Research Bulletin. 26: 309-311. PMID 2012991 DOI: 10.1016/0361-9230(91)90243-D |
0.373 |
|
| 1991 |
Jolicoeur FB, Michaud J, Rivest R, Menard D, Gaudin D, Fournier A, St-Pierre S. Neurobehavioral profile of neuropeptide Y. Brain Research Bulletin. 26: 265-268. PMID 2012986 DOI: 10.1016/0361-9230(91)90237-E |
0.353 |
|
| 1991 |
Dumont Y, Fournier A, St-Pierre S, Schwartz TW, Quirion R. Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. European Journal of Pharmacology. 191: 501-3. PMID 1964914 DOI: 10.1016/0014-2999(90)94189-5 |
0.342 |
|
| 1991 |
Bleakman D, Colmers WF, Fournier A, Miller RJ. Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor. British Journal of Pharmacology. 103: 1781-9. PMID 1718523 DOI: 10.1111/J.1476-5381.1991.Tb09863.X |
0.343 |
|
| 1991 |
Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. British Journal of Pharmacology. 104: 797-804. PMID 1667286 DOI: 10.1111/J.1476-5381.1991.Tb12509.X |
0.332 |
|
| 1991 |
Bitran M, Torres G, Fournier A, Pierre SS, Pablo Huidobro-Toro J. Age and castration modulate the inhibitory action of neuropeptide Y on neurotransmission In the rat vas deferens European Journal of Pharmacology. 203: 267-274. PMID 1666047 DOI: 10.1016/0014-2999(91)90723-4 |
0.312 |
|
| 1991 |
Kalra SP, Dube MG, Fournier A, Kalra PS. Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists Physiology and Behavior. 50: 5-9. PMID 1658831 DOI: 10.1016/0031-9384(91)90490-F |
0.394 |
|
| 1991 |
Colmers WF, Klapstein GJ, Fournier A, St-Pierre S, Treherne KA. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. British Journal of Pharmacology. 102: 41-4. PMID 1646061 DOI: 10.1111/J.1476-5381.1991.Tb12129.X |
0.39 |
|
| 1991 |
Dumont Y, Van Rossum D, Dennis T, Fournier A, St-Pierre S, Quirion R. Autoradiographic localization of putative CGRP receptor subtypes in rat brain Regulatory Peptides. 34: 95. DOI: 10.1016/0167-0115(91)90405-6 |
0.337 |
|
| 1991 |
Quirion R, Dennis T, Van Rossum D, Mimeault M, Dumont Y, Fournier A, St-Pierre S. Evidence for CGRP receptor sub-types using selective agonists and antagonists Regulatory Peptides. 34: 77. DOI: 10.1016/0167-0115(91)90374-P |
0.336 |
|
| 1990 |
Forest M, Martel JC, St-Pierre S, Quirion R, Fournier A. Structural study of the N-terminal segment of neuropeptide tyrosine. Journal of Medicinal Chemistry. 33: 1615-9. PMID 2342055 DOI: 10.1021/Jm00168A014 |
0.393 |
|
| 1990 |
Forest M, Fournier A. BOP reagent for the coupling of pGlu and Boc-His(Tos) in solid phase peptide synthesis International Journal of Peptide and Protein Research. 35: 89-94. PMID 2323890 DOI: 10.1111/J.1399-3011.1990.Tb00240.X |
0.316 |
|
| 1990 |
Cadieux A, Pomerleau F, St-Pierre S, Fournier A. Inhibitory action of calcitonin gene-related peptide (CGRP) in the mouse colon. Journal of Pharmacy and Pharmacology. 42: 520-521. PMID 1980300 DOI: 10.1111/J.2042-7158.1990.Tb06612.X |
0.367 |
|
| 1990 |
Donoso MV, Fournier A, St-Pierre S, Huidobro-Toro JP. Pharmacological characterization of CGRP1 receptor subtype in the vascular system of the rat: Studies with hCGRP fragments and analogs Peptides. 11: 885-889. PMID 1704613 DOI: 10.1016/0196-9781(90)90003-N |
0.339 |
|
| 1990 |
CADIEUX A, T-BENCHEKROUN M, FOURNIER A, ST-PIERRE S. Pharmacological Actions of Neuropeptide Y and Peptide YY in Rat Colon Annals of the New York Academy of Sciences. 611: 372-375. DOI: 10.1111/J.1749-6632.1990.Tb48954.X |
0.365 |
|
| 1989 |
Cadieux A, -Benchekroun MT, St-Pierre S, Fournier A. Bronchoconstrictor action of neuropeptide Y (NPY) in isolated guinea pig airways Neuropeptides. 13: 215-219. PMID 2747854 DOI: 10.1016/0143-4179(89)90073-5 |
0.358 |
|
| 1988 |
Fournier A, Saunders JK, Boulanger Y, St-Pierre SA. Conformational analysis of vasoactive intestinal peptide and related fragments Annals of the New York Academy of Sciences. 527: 51-57. PMID 3389647 DOI: 10.1111/J.1749-6632.1988.Tb26972.X |
0.331 |
|
| 1984 |
Leroux P, Vaudry H, Fournier A, St-Pierre S, Pelletier G. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung. Endocrinology. 114: 1506-12. PMID 6325122 DOI: 10.1210/Endo-114-5-1506 |
0.394 |
|
| 1982 |
Fournier A, Couture R, Regoli D, Gendreau M, St-Pierre S. Synthesis of peptides by the solid-phase method. 7. Substance P and analogues. Journal of Medicinal Chemistry. 25: 64-8. PMID 6177855 DOI: 10.1021/Jm00343A012 |
0.367 |
|
| 1980 |
Fournier A, Couture R, Magnan J, Gendreau M, Regoli D, St-Pierre S. Synthesis of peptides by the solid-phase method. V. Substance P and analogs. Canadian Journal of Biochemistry. 58: 272-80. PMID 6155184 DOI: 10.1002/Chin.198228309 |
0.36 |
|
| 1979 |
Couture R, Fournier A, Magnan J, St-Pierre S, Regoli D. Structure–activity studies on substance P Canadian Journal of Physiology and Pharmacology. 57: 1427-1436. DOI: 10.1139/Y79-211 |
0.352 |
|
| Show low-probability matches. |